According to latest data from National cancer registry, the estimated number of incident cases of cancer in India in 2022 was ...

Doctors at AIIMS, Delhi are developing a low-cost antibody-based adaptive cellular therapy for treatment of multiple myeloma, a form of blood cancer.

BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), announces that it has entered ...

"BrightPath and Cellistic partner for clinical trial advancements of CAR-T cell therapy" was originally created and published ...

Roswell Park Comprehensive Cancer Center next month will open a $98 million facility dedicated to developing new cancer ...

Findings reveal that metabolic enzymes ACSS2 and ACLY regulate T cell exhaustion, linking nutrient metabolism to epigenetic ...

For CRISPR Therapeutics specifically, that financial flexibility is not necessarily needed even if it's a plus. As of the most recent quarter, Q3, it reported having around $1.9 billion in cash, ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science ...

As the founder and CEO of Immunocine Cancer Center, based in Cancún, Mexico, he has transformed his vision into reality with ...

Combining phototherapy with chemotherapy may provide a more powerful approach to combat aggressive tumors effectively.

Reaching the end of a long road to approval, the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...